Vas Narasimhan

Person

Last mentioned: 2d ago

Timeline

  1. Market Assessment

    Analysts begin evaluating the long-term impact on Novartis's margins and the broader pharma supply chain.

  2. Expansion Announcement

    President Trump publicly states that Novartis will expand its U.S. manufacturing footprint due to tariffs.

  3. White House Meeting

    CEO Vas Narasimhan meets with President Trump to discuss the pharmaceutical industry and trade.

Stories mentioning Vas Narasimhan 1

pharma Neutral

Trump Credits Tariffs for Novartis Manufacturing Expansion in US

President Donald Trump announced that Novartis AG will expand its U.S. manufacturing footprint following a White House meeting with CEO Vas Narasimhan. The administration attributes this shift to the impact of trade tariffs, signaling a potential trend of onshoring for major pharmaceutical players.

2 sources